Ambient ionization mass spectrometry imaging platform for direct mapping from bulk tissue
A method of ion imaging is disclosed that includes automatically sampling a plurality of different locations on a sample using a front device which is arranged and adapted to generate aerosol, smoke or vapour from the sample. Mass spectral data and/or ion mobility data corresponding to each location is obtained and the obtained mass spectral data and/or ion mobility data is used to construct, train or improved a sample classification model.
1. A method of ion imaging comprising:
automatically sampling a plurality of different locations on a sample using a laser device arranged and adapted to generate aerosol, smoke or vapour from the sample;
automatically translating said sample relative to said laser device before and/or during and/or after obtaining mass spectral data and/or ion mobility data from at least some of said locations on said sample;
providing a collision surf surface located within a vacuum chamber of a mass spectrometer and/or ion mobility spectrometer so as to generate analyte ions;
adding a matrix to said aerosol, smoke or vapour generated by said laser device to form a mixture of said aerosol, smoke or vapour and said matrix prior to said aerosol, smoke or vapour impacting upon said collision surface;
passing said mixture of said aerosol, smoke or vapour and said matrix into the vacuum chamber of the mass spectrometer and/or ion mobility spectrometer;
causing at least some of said mixture of said aerosol, smoke or vapour and said matrix to impact upon said collision surface wherein at least some of said aerosol, smoke or vapour is ionized upon impacting said collision surface so as to generate analyte ions;
obtaining mass spectral data and/or ion mobility data corresponding to each said location; and
using said obtained mass spectral data and/or ion mobility data to construct, train or improve a sample classification model;
wherein said matrix comprises isopropanol.
2. The method as claimed in claim 1 , wherein said sample comprises a biological sample, biological tissue, human tissue, animal tissue, biological matter, a bacterial colony, a fungal colony or one or more bacterial strains.
3. The method as claimed in claim 1 , wherein said sample comprises native or unmodified sample material, optionally wherein said native or unmodified sample material is unmodified by the addition of a matrix or reagent.
4. The method as claimed in claim 1 , wherein said sample classification model comprises a biological sample classification model, a biological tissue classification model, a human tissue classification model, an animal tissue classification model or a bacterial strain classification model.
5. The method as claimed in claim 1 , further comprising constructing, training or improving said sample classification model in order either: (i) to distinguish between healthy and diseased tissue; (ii) to distinguish between potentially cancerous and non-cancerous tissue; (iii) to distinguish between different types or grades of cancerous tissue; (iv) to distinguish between different types or classes of sample material; (v) to determine whether or not one or more desired or undesired substances are present in said sample; (vi) to confirm the identity or authenticity of said sample; (vii) to determine whether or not one or more impurities, illegal substances or undesired substances are present in said sample; (viii) to determine whether a human or animal patient is at an increased risk of suffering an adverse outcome; (ix) to make or assist in the making a diagnosis or prognosis; and (x) to inform a surgeon, nurse, medic or robot of a medical, surgical or diagnostic outcome.
6. The method as claimed in claim 1 , wherein the step of using said obtained mass spectral data and/or ion mobility data to construct, train or improve said sample classification model comprises performing a supervised or unsupervised multivariate statistical analysis of said mass spectral data and/or ion mobility data, optionally wherein said multivariate statistical analysis is selected from the group consisting of: (i) principal component analysis (“PCA”); and (ii) linear discriminant analysis (“LDA”).
7. The method as claimed in claim 1 , further comprising heating said collision surface optionally to a temperature selected from the group consisting of: (i) 200-300° C.; (ii) 300-400° C.; (iii) 400-500° C.; (iv) 500-600° C.; (v) 600-700° C.; (vi) 700-800° C.; (vii) 800-900° C.; (viii) 900-1000° C.; (ix) 1000-1100° C.; and (x) >1100° C.
8. A mass spectrometer and/or ion mobility spectrometer comprising:
a laser device arranged and adapted to generate aerosol, smoke or vapour from a sample;
a device arranged and adapted to automatically translate said sample relative to said laser device any one or more of before, during, and after obtaining mass spectral data and/or ion mobility data from at least some of said locations on said sample;
a device arranged and adapted to add a matrix to said aerosol, smoke or vapour generated by said laser device to form a mixture of said aerosol, smoke or vapour and said matrix;
a collision surface located within a vacuum chamber of a mass spectrometer and/or ion mobility spectrometer wherein in use at least some of said mixture of said aerosol, smoke or vapour and said matrix is caused to impact upon said collision surface and at least some of said aerosol, smoke or vapour is ionized upon impacting said collision surface so as to generate analyte ions; and
a control system arranged and adapted:
(i) to automatically sample a plurality of different locations on said sample using said first laser device and to obtain mass spectral data and/or ion mobility data corresponding to each said location; and
(ii) to use said obtained mass spectral data and/or ion mobility data to construct, train or improve a sample classification model;
wherein said matrix comprises isopropanol.
9. The mass spectrometer and/or ion mobility spectrometer as claimed in claim 8 , wherein said sample comprises a biological sample, biological tissue, human tissue, animal tissue, biological matter, a bacterial colony, a fungal colony or one or more bacterial strains.
10. The mass spectrometer and/or ion mobility spectrometer as claimed in claim 8 , wherein said sample classification model comprises a biological sample classification model, a biological tissue classification model, a human tissue classification model, an animal tissue classification model or a bacterial strain classification model.
11. The mass spectrometer and/or ion mobility spectrometer as claimed in claim 8 , further comprising a heater which is optionally arranged and adapted to heat said collision surface to a temperature selected from the group consisting of: (i) 200-300° C.; (ii) 300-400° C.; (iii) 400-500° C.; (iv) 500-600° C.; (v) 600-700° C.; (vi) 700-800° C.; (vii) 800-900° C.; (viii) 900-1000° C.; (ix) 1000-1100° C.; and (x) >1100° C.